Open source drug discovery– A new paradigm of collaborative research in tuberculosis drug development
- 30 September 2011
- journal article
- review article
- Published by Elsevier in Tuberculosis
- Vol. 91 (5), 479-86
- https://doi.org/10.1016/j.tube.2011.06.004
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 2010
- Can Open-Source Drug R&D Repower Pharmaceutical Innovation?Clinical Pharmacology & Therapeutics, 2010
- Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosisMolecular BioSystems, 2009
- An Indian effort towards affordable drugs: “Generic to designer drugs”Biotechnology Journal, 2009
- Multidrug-resistant and extensively drug-resistant tuberculosis: a reviewCurrent Opinion in Infectious Diseases, 2008
- India Takes an Open Source Approach to Drug DiscoveryCell, 2008
- Biopharmaceutics, Pharmacokinetics and Pharmacodynamics of Antituberculosis DrugsCurrent Medicinal Chemistry, 2008
- Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosisNature Reviews Microbiology, 2008
- New Approaches to Filling the Gap in Tuberculosis Drug DiscoveryPLoS Medicine, 2007
- CoPS: Comprehensive Peptide Signature DatabaseBioinformatics, 2004